We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $412M
1-Year Est. Return 18.33%
This Fund
S&P 500
This Quarter Est. Return
-7.72%
1 Year Est. Return
+18.33%
3 Year Est. Return
+56.05%
5 Year Est. Return
+49%
10 Year Est. Return
+255.15%
AUM
$2.56B
AUM Growth
-$180M
Cap. Flow
+$70.2M
Cap. Flow %
2.74%
Top 10 Hldgs %
33.02%
Holding
158
New
28
Increased
55
Reduced
47
Closed
27

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.86%
2 Utilities 17.25%
3 Consumer Staples 16.06%
4 Healthcare 12.94%
5 Materials 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAHO
151
DELISTED
Tahoe Resources Inc
TAHO
-13,800
Closed -$167K
ESRX
152
DELISTED
Express Scripts Holding Company
ESRX
-51,287
Closed -$4.56M
TWX
153
DELISTED
Time Warner Inc
TWX
-177,311
Closed -$15.5M
DD
154
DELISTED
Du Pont De Nemours E I
DD
-46,170
Closed -$2.8M
BRCM
155
DELISTED
BROADCOM CORP CL-A
BRCM
-97,557
Closed -$5.02M
PCP
156
DELISTED
PRECISION CASTPARTS CORP
PCP
-66,851
Closed -$13.4M
HCBK
157
DELISTED
HUDSON CITY BANCORP INC
HCBK
-61,884
Closed -$611K
DO
158
DELISTED
Diamond Offshore Drilling
DO
-1,523,180
Closed -$39.3M

Similar funds

TOBAM's Q3 2015 Portfolio in Review

As of Q3 2015, TOBAM held 158 positions worth $2.56B, down 6.6% from $2.74B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

TOBAM's Q3 2015 filing shows 28 new, 55 increased, 47 reduced and 27 closed positions. Its largest new stake was Cobalt International Energy, Inc: 229,660 shares worth $24.4M. The largest sale was Vertex Pharmaceuticals, an estimated $42.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 18% a quarter earlier, followed by Utilities and Consumer Staples.

  • TOBAM's largest Q3 2015 buy was Cobalt International Energy, Inc: 229,660 shares worth $24.4M.
  • TOBAM added most to Humana in Q3 2015, an estimated $56.5M increase.
  • TOBAM's biggest Q3 2015 reduction was Dollar General, cutting an estimated $31.6M.
  • TOBAM fully exited Vertex Pharmaceuticals in Q3 2015, selling an estimated $42.4M.
  • TOBAM's ten largest holdings make up 33% of its $2.56B portfolio in Q3 2015.
  • TOBAM opened 28 new positions and closed 27 in Q3 2015.
  • TOBAM's portfolio value fell 6.6% quarter-over-quarter to $2.56B.

Based on TOBAM's 13F filing for Q3 2015, filed 20 Nov 2015.